1 / 40

PIH/Preeclampsia

PIH/Preeclampsia. Jeff Katz, MD. Gestational Hypertension. Systolic > 140 mmHg Diastolic > 90 mmHg Occurs after 20 weeks in gestation Returns to baseline postpartum. Preeclampsia. Gestational HTN + Proteinuria Occurs after 20 weeks in gestation Returns to baseline postpartum Dx:

michiko
Télécharger la présentation

PIH/Preeclampsia

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. PIH/Preeclampsia Jeff Katz, MD

  2. Gestational Hypertension • Systolic > 140 mmHg • Diastolic > 90 mmHg • Occurs after 20 weeks in gestation • Returns to baseline postpartum

  3. Preeclampsia • Gestational HTN + Proteinuria • Occurs after 20 weeks in gestation • Returns to baseline postpartum • Dx: • Pt was previously normotensive • BP > 140/90 after 20 weeks • Proteinuria – urinary excretion of > 0.3 g of protein in a 24 hr urine specimen

  4. Preeclampsia • Scope of Problem: • Hypertensive Disease: • Occurs in 12-22% of pregnancies • Responsible for 17.6% of maternal deaths in USA • Preeclampsia • Approx. 5-8% of pregnancies • Primarily the 1st pregnancy (>80%) • Genetic disposition

  5. Classification • Hypertensive Disorders • Gestational HTN: • Preeclampsia – mild and severe • Eclampsia • HELLP Syndrome – Hemolysis, Elevated Liver enzymes, Low Plts • Chronic HTN pre-pregnancy • Chronic HTN w/ superimposed gestational HTN • Superimposed preecampsia • Superimposed eclampsia

  6. Pathogenesis • Etiology unknown • Related to degree of trophoblastic invasion by the placenta • In preeclampsia, the invasion is incomplete • Severity of invasion may be related to degree of invasion • Associated with alterations in immune response

  7. Pathogenesis • Occurs only in presence of placental issue • Strong genetic component • Associated with failure of 2nd trophoblastic invasion (14-16 weeks) • Results in high resistance low-flow uteroplacental circulation (ischemia) • Very complicated vascular active proteins involved - PGs, TXs, Endothelin, Endothelium derived relaxing factor • Plt dysfunction (aggregation)

  8. Hypertensive Disease • Risks: • Group 1 (Hypertensive dz): • Previous preeclampsia • Systolic HTN < 20 wks gest • H/o chronic HTN • Family h/o previous PIH

  9. Hypertensive Disease • Risks: • Group 2 (Coexisting vascular and endothelial dz): • Chronic renal dz • Lupus erythematous • Protein S deficiency • Circulating anticardiolipin antibodies

  10. AA Angiotensin gene T235 Nulliparity > 40 yrs old H/o not smoking Obesity Inc trophoblastic mass Large for gestational age Diabetes Erythroblastosis fetalis Polyhydramnios (young primups) Hypertensive Disease • Risks: Group 3: (obstetric factors)

  11. Preeclampsia • Severe preeclampsia – signs: • BP > 160 sys., > 110 dias. • Proteinuria > 5 gm in 24 hrs • Oliguria <400 ml in 24 hrs • Cerebral/visual disturbances • Pulmonary edema (cyanosis) • Epigastric/RUQ pain • Impaired liver function, rupture • Thrombocytopenia • HELLP syndrome • IUGR, oligohydramnios

  12. Preeclampsia - Pathophsiology • Cardiovascular: • Blood Pressure: • Labile • Hypersensitive to vasoactive hormones • ? Sympathetic overactivity • Vascular spasm • Inc SVR • Sustained HTN

  13. Preeclampsia - Pathophsiology • Cardiovascular: • Blood Volume: • Reduced 9-40% depending on severity • Behave as if vasoconstricted • HR, BP variability increased • Replace volume carefully – be careful of pulmonary edema • Hemodynamic change: • Initially hyperdynamic, later dec CO w/ inc SVR • Great variation • CO/SVR change throughout pregnancy

  14. Preeclampsia - Pathophsiology • Cardiovascular: • Cardiac function: • Normal heart rate • Poor correlation b/w CVP & PCWP • Variable • V. sensitive to rapid fluid bolus • Colloid oncotic pressure: • Dec in nml pregnancy, more w/ preeclampsia • Drops from 22 mmHg to 17 mmHg in nml; 22 to 14 in PIH • Low COP, inc vasc permeability, and loss of fluid & protein into tissues makes edema likely

  15. Preeclampsia - Pathophsiology • Hematological: • Hypercoagulability: • Accelerated PT – increased common pathway activity, inc activity of Factors II, V, X, reduced fibrinogen • RBC membrane anomaly – triggers thrombin formation • Reduced Antithrombin III – normally inhibits coagulation factors

  16. Preeclampsia - Pathophsiology • Hematological: • Fibrinolysis: • Variable opinions • Reduced fibrinolytic activity – altered activity b/w plasminogen activators and inhibitors adds to presence of fibrin in renal and placental vasculature • Higher Lipoprotein (a) concentration – competes with plasminogen for binding sites

  17. Preeclampsia - Pathophsiology • Hematological: • Platelet activation – Thrombocytopenia: • In 15-30% of PIH/eclampsia • < 10% have PLT count < 100,000 • Marked daily variation • Prolonged bleeding time in some • Inc release of beta- thromboglobulin by PLTs • Shorter PLT production time • Appearance of megathrombocytes

  18. Preeclampsia - Pathophsiology • Renal Function: • Glomerulopathy: • Glomerular enlargement w/ ischemia as a result of swollen intracapillary cells • GFR 25% below nml gestational • Non-pregnant = 122ml/min • Pregnant = 170ml/min • Proteinuria • Inc permeability to large moleclar wt proteins • Amt of proteinuria correlates w/ histological change and HTN

  19. Preeclampsia - Pathophsiology • Renal Function: • Glomerulopathy: • Oliguria • Parallels severity of eclampsia: <400ml/24 hr calls for intravascular fluid volume evaluation • Renal failure is rare, recovery is expected

  20. Preeclampsia - Pathophsiology • Renal Function: • Edema & weight gain: • Generalized edema is common • Important in airway mgmt – difficult airway and bleeding • Assoc w/ excessive wt gain through pregnancy • If severe PIH then pulmonary edema may follow

  21. Preeclampsia - Pathophsiology • Respiratory: • Pharyngolaryngeal edema • Airway narrowing • Fragile mucous membranes - bleeding • Pulmonary edema • More likely in severe PIH, or eclampsia • Occurs in 3% of cases • Occurred antepartum in 30% of cases • Occurred postpartum in 70% of cases

  22. Preeclampsia - Pathophsiology • Hepatic Changes: • Elevated transaminases • Subcostal/ RUQ pain – caused by edema or bleeding • Subcapsular bleeding • Suspect w/ severe abd pain • Could also be parenchymal bleeding • If capsule disrupted – intraperitoneal hemorrhage – surgical emergency

  23. Preeclampsia - Pathophsiology • Neurological: • HA, visual disturbances, CNS hyperexcitability, hyperreflexia • Seizures = eclampsia – causes • Hypertensive encephalopathy • Loss of cerebral autoregulation • Vasospasm • Microinfarctions, punctate hemorrhages • Thrombosis • Cerebral edema

  24. Preeclampsia - Pathophsiology • Uteroplacental perfusion • Decreased • Common in IUGR, oligohydramnios • High resistance – low flow (nml is low resistance – high flow) • Fetus does not tolerate the hypotension assoc w/ regional anesthesia – monitor FHR

  25. Preeclampsia - Prevention • Aspirin prophylaxis: • Based on reversing the PLT abnormalities • Increases PGI2 production, inhibits TXA2 synthesis • Use low doses – 60 mg/day • Early studies encouraging • Later studies showed no benefit • Calcium prophylaxis: • No benefit

  26. Effect of Pregnancy on Preeclampsia • Only cure for PIH is to end pregnancy • Women w/ placenta previa at less risk for PIH • Placenta previa and PIH not mutually exclusive

  27. Effect of Preeclampsia on Pregnancy • Position pt in lateral recumbent position to maximize uteroplacental perfusion • Induce labor if: • > 37 wks • Fetal lungs are matue • Favorable cervix • Increasing BP despite tx

  28. Drug Therapy • Magnesium Sulfate: • Anticonvulsant of choice • Tocolytic • Loading dose – 4-6 gm over 20 mins • Maint dose – 1-2 gm/hr infusion • Therapeutic range – 5-9 mg/dL • Monitor: • Reflexes, UO, resp rate, muscle strength • If toxic: Discontinue, give Ca2+, support ventilation

  29. Drug Therapy • Magnesium Sulfate: • Does not prolong nml/induced labor • Does not inc rate of C/S • Requires inc oxytocin for labor • Better results than phenytoin, diazepam

  30. Drug Therapy • Antihypertensives: • Methyldopa – choice of OBs • Parenteral drugs if severe or acute • No adverse effect on uteroplacental perfusion, fetal circulation • Do not defer or prevent PIH, IUGR, or perinatal death

  31. Drug Therapy • Antihypertensives: • Hydralazine: • Used for acute control IV • 5 mg IV Q 20 mins w/ a max of 20 mg • Side effects: tachycardia (inc SV, CO), HA, nausea, hypotension • Labetalol: • Combined alpha and beta • Ratio of 1:7 if given IV • Initial dose = 10-20 mg IV. Can double dose every 10 mins if necessary – max = 300mg • Reduces BP, SVR, slows HR.

  32. Drug Therapy • Antihypertensives: • Nitroglycerine: • Relaxes smooth muscle • Venous > Arterial • Reduces preload > afterload • Always expand volume before using because of sudden drop • Dilute to 50 mg/ 500 ml (100 mcg/ml) • Initial dose = 0.5-1 mcg/kg/min • Increase by 0.5 mcg/kg/min until satisfactory

  33. Drug Therapy • Antihypertensives: • Sodium nitroprusside • Arterial dilator – reduces afterload • Less preload reduction • Crosses placenta – could cause fetal cyanide toxicity • Initial dose = 0.5 mcg/kg/min • Toxicity seen if dose > 4 mcg/min

  34. Drug Therapy • Antihypertensives: • Nifedipine: • Calcium channel blocker • Effects mainly arterial smooth muscle • 10 mg sublingual, repeat in 30 mins • 10-20 mg Q 3-6 hrs • Could see exaggerated response w/ MgSO4 • Facial fkushing, HA, tachycardia

  35. Oliguria • < 30 ml/hr for 3 hrs • Confirm Foley location • 300-500 ml fluid challenge • If still a problem, insert a CVP • If CVP low, give fluids. If OK, give nitroglycerine to dilate renal artery • CVP does not mirror PCWP in severe PIH • Can push PCWP to 12-14 mmHg

  36. HELLP Syndrome • Hemolysis, Elevated Liver Enzymes, Low Platelets and PIH • Differential Dx: • Hepatitis, gallbladder dz, acute fatty liver of pregnancy, thrombocytopenic purpura (TTP) • Etiology unknown • 20% present postpartum, the rest preterm • Peak is 24-48 hrs postpartum • Initial c/o RUQ pain • 50% have NV • 80% have PIH before dx

  37. HELLP Syndrome • Complications: • DIC • Placental abruption • Need for blood transfusion • Pleural effusion • Acute renal failure • Wound infection • If develops postpartum there is a higher incidence of pulmonary edema and renal failure

  38. HELLP Syndrome • Time course of thrombocytopenia is v. important • If stable at 80,000 PLT, then regional is OK • If dropping fast at 80,000, then regional is dangerous – epidural hematoma • Treatment - delivery

  39. Preanesthetic Evaluation • Fluid status • Hemodynamic status • Coagulation status • Bleeding time • PLT count • PT/aPTT • TEG

  40. Anesthetic Mgmt • Technique – Epidural vs. Spinal • Treatment of side effects: • Hypotension • Difficult airway • Coagulation • Urgent C/S • Postpartum • Analgesia • Fluid balance • MgSO4 • Hemodynamic control

More Related